Inventor
Frank Hallock Ebetino
Inventor
Cincinnati, OH, US
Overview
Patents· 33 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Fprimary
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium37%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
A61KPreparations for medical, dental or toiletry purposes13%
C07DHeterocyclic compounds7%
C07KPeptides6%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%
PatentTitleYear
10,865,220Bisphosphonate quinolone conjugates and uses thereof202010,857,165Skeletal removal of bisphosphonates202010,660,884Phosphonate-chloroquine conjugates and methods using same20208,822,435'Bisphosphonate compounds'20148,710,215'Bisphosphonate compounds'20148,618,079'Imidazo[1,2-a] pyridinyl bisphosphonates'20138,314,081'Bisphosphonate compounds'20128,252,774'5-azaindole bisphosphonates'20127,781,418'Composition for treating bone disorders'20107,132,539'Melanocortin receptor ligands'20067,087,759'Melanocortin receptor ligands'20067,026,335'Melanocortin receptor ligands'20066,951,916'Melanocortin receptor ligands'20056,911,447'Melanocortin receptor ligands'20056,613,874'Melanocortin receptor ligands'20036,372,730'2-decarboxy-2-phosphinico Prostaglandin F analogs'20025,856,314'Thio-substituted, Nitrogen-containing, heterocyclic phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism'19995,824,661'Sulfur-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism'19985,770,586'Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism amd methods of treating and preventing dental calculus and plaque'19985,763,611'Thio-substituted cyclic phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism'19985,760,021'Phosphonocarboxylate compounds pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism'19985,753,634'Quaternary nitrogen containing phosphonate compounds, pharmaceutical compostions, and methods for treating abnormal calcium and phosphate metabolism'19985,731,299'Phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism'19985,574,024'Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism'19965,519,013'Heterocycle-substituted diphosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism'19965,393,746'Bicyclic diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism'19955,391,743'Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque'19955,334,586'Heterocycle-substituted diphosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism'19945,137,880'Bicyclic diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism'19925,128,244'Assay for dioxins'19925,071,840'Certain heterocyclic substituted diphosphonate compounds pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism'19914,963,681'Process for synthesis of aminomethylene phosphonoalkylphosphinates'19904,868,164'Octahydro-pyridine diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism'1989Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1989–1992Patents assigned to NORWICH EATON PHARMA (4)· patent assignee history
1989–1996Based in Norwich, NY, US· patent location history
1995–2014Based in Cincinnati, OH, US· patent location history
1996–2006Patents assigned to PROCTER & GAMBLE (15)· patent assignee history
2010–2013Patents assigned to ISIS INNOVATION (3)· patent assignee history
2012–2013Patents assigned to EBETINO FRANK HALLOCK (3)· patent assignee history
2012–2014Patents assigned to WARNER CHILCOTT CO LLC (3)· patent assignee history
2020Based in Venice, FL, US· patent location history
2020Based in Pasadena, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PROCTER & GAMBLE | 15 | 1996–2006 |
| NORWICH EATON PHARMA | 4 | 1989–1992 |
| EBETINO FRANK HALLOCKself | 3 | 2012–2013 |
| ISIS INNOVATION | 3 | 2010–2013 |
| WARNER CHILCOTT CO LLC | 3 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Cincinnati, OH, US | 21 | 1995–2014 |
| Norwich, New York, US | 9 | 1989–1996 |
| Venice, Florida, US | 2 | 2020 |
| Pasadena, California, US | 1 | 2020 |